To evaluate the efficacy of a new multimodal antidepressant, vortioxetine (VO), in the management of burning mouth syndrome (BMS).
Vortioxetine in the Treatment of Mood Disorders Associated with Burning Mouth Syndrome: Results of an Open-Label, Flexible-Dose Pilot Study / Adamo, Daniela; Pecoraro, Giuseppe; Aria, Massimo; Favia, Gianfranco; Mignogna, Michele Davide. - In: PAIN MEDICINE. - ISSN 1526-2375. - (2020). [10.1093/pm/pnz120]
Vortioxetine in the Treatment of Mood Disorders Associated with Burning Mouth Syndrome: Results of an Open-Label, Flexible-Dose Pilot Study
Aria, Massimo;Mignogna, Michele Davide
2020
Abstract
To evaluate the efficacy of a new multimodal antidepressant, vortioxetine (VO), in the management of burning mouth syndrome (BMS).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
